The science of success: UK biotech in 2020

New data published by the UK BioIndustry Association (BIA) and Clarivate PLC reveals that UK biotech companies raised a record £2.8 billion in equity finance in 2020. The science of success: UK biotech in 2020, marks the best year for biotech investments ever recorded by the trade association and shows that since 2012 investment has increased by over 1000%.


Download the report

Biotech companies on London stock markets delivered market-beating returns in 2020

Biotech companies on London stock markets delivered market-beating returns in 2020 and attracted new investors looking for growth in a turbulent year, according to new analysis by the UK BioIndustry Association (BIA) and Radnor Capital Partners.


READ THE ANALYSIS

The BIA campaigns for finance, tax and investment policies to support UK bioscience companies to start and scale-up.

The Finance and Tax Advisory Committee (FTAC) leads the BIA’s policy development, drawing on the expertise and experience of the membership. Our strong links to the Treasury, HMRC and the Department for Business, Energy and Industrial Strategy ensure that the voice of the bioscience sector is heard at the highest levels.

FTAC also provides finance and tax support for BIA members through events and guidance documents. 

The BIA works with the investment community to raise to profile of UK bioscience and publishes quartlery reports on the levels of investment in the sector. The UK is the European leader in bioscience investment and is in a strong position to close the gap on the leading life sciences clusters in Boston and San Francisco and achieve the BIA's vision of becoming the world's third largest global biotech cluster. Check out the image gallery below for more on our 2019 finance report, Global and growing - UK biotech financing in 2019.